1992
DOI: 10.1016/s1010-5182(05)80319-1
|View full text |Cite
|
Sign up to set email alerts
|

The role of radiotherapy in the management of salivary gland carcinomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

1997
1997
2021
2021

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(3 citation statements)
references
References 20 publications
1
2
0
Order By: Relevance
“…The present study confirmed that status of surgical margins was an important independent predictor of both survival and locoregional control (VI, Fu et al 1977, Tran et al 1986, O'Brien et al 1986, Kane et al 1991, Shingaki et al 1992, Poulsen et al 1992,Teshima et a1 1993, Anderson et al 1995, Malata et al 1997. Only free surgical margins were of importance for survival, whereas locoregional control was related to the amount of tumour left at surgery (VI).…”
Section: Treatmentsupporting
confidence: 81%
“…The present study confirmed that status of surgical margins was an important independent predictor of both survival and locoregional control (VI, Fu et al 1977, Tran et al 1986, O'Brien et al 1986, Kane et al 1991, Shingaki et al 1992, Poulsen et al 1992,Teshima et a1 1993, Anderson et al 1995, Malata et al 1997. Only free surgical margins were of importance for survival, whereas locoregional control was related to the amount of tumour left at surgery (VI).…”
Section: Treatmentsupporting
confidence: 81%
“…In general, malignant salivary gland tumors are considered to be radio-resistant, and radical surgery is the first treatment of choice 11 . BNCT is a tumorselective, high LET radiation therapy with relatively high biological effect, therefore it should work well even for radio-insensitive tumors, compared with low LET radiation therapy using photons 8 .…”
Section: Discussionmentioning
confidence: 99%
“…Survival rates have also been reported to improve as the relative risk of cancer‐related deaths and deaths from any cause in those treated by surgery alone are 2.21 and 1.67 times greater than that receiving adjuvant radiotherapy for head and neck SCCs 37 . Despite this, disease‐free survival rates were not significantly improved with the use of adjuvant radiotherapy but determined by crucial factors such as positive surgical margins and presence of lymph node metastasis which indicate a high risk of locoregional recurrence and/or systemic metastasis 36,38–42 …”
Section: Introductionmentioning
confidence: 99%